SCHEMBL7517024

SCHEMBL7517024

O=C(O)C(=O)Nc1sc2c(c1C(=O)O)C[C@H](CNC(=O)c1ccc(NC(=O)c3ccccc3)cc1)NC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.44
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.44
ESR2 Q92731 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TP53 P04637 2/20 0.43
PTPN1 P18031 8/20 0.42
PTPN2 P17706 5/20 0.42
PTPRC P08575 2/20 0.42
RAB7A P51149 2/20 0.40
KDM4E B2RXH2 1/20 0.39
TNF P01375 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7519819 1.00 RAB9A (0.44) RAB9AMAPTSMN1; SMN2LMNAPOLB
SCHEMBL7519532 0.94 PTPN1 (0.47) RAB9AMAPTSMN1; SMN2LMNAPOLB
SCHEMBL7522183 0.91 PTPN1 (0.46) RAB9AMAPTSMN1; SMN2LMNAPOLB
SCHEMBL7520464 0.89 PTPN1 (0.44) RAB9AMAPTSMN1; SMN2LMNAPOLB
SCHEMBL7513085 0.87 PTPN1 (0.47) RAB9AKMT2ANPC1PTPN1PTPN2
SCHEMBL7520917 0.86 PTPN1 (0.42) RAB9AMAPTSMN1; SMN2LMNAPOLB
SCHEMBL7525515 0.84 RAB9A (0.45) RAB9AMAPTPOLBMEN1KMT2A
SCHEMBL7515936 0.84 PTPN1 (0.43) MEN1KMT2APTPN1PTPN2PTPRC
SCHEMBL7513118 0.82 PTPN1 (0.41) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL7520327 0.81 PTPN1 (0.43) RAB9AMAPTHPGDNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US claimed
WO-2002004458-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-17 WO claimed
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US disclosed
WO-2002004458-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPN1, PTPRO, PTPRS RAB9A 3157/4885MAPT 3880/4885SMN1; SMN2 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.